StratDeck

Two stocks in Specialty Chemicals

Givaudan vs Novonesis A/S: profit, growth, debt and price compared

Novonesis A/S is stronger on 5 of 7 figures: profit margin, sales growth, debt, price for its expected profit and analysts' view. Givaudan is stronger on 2: dividend and price trend.

Figures as of 18 November 2026Yahoo Finance
Explore Givaudan's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Givaudan and Novonesis A/S side by side
GivaudanGIVN.SWNovonesis A/SNSIS-B.CO
Net margin12.9%Stronger: 15.6%
Revenue growth, past year−1.70%Stronger: +7.10%
Debt to equity110.8%Stronger: 27.9%
Forward P/E30.1×Stronger: 26.0×
Dividend yieldStronger: 1.77%1.46%
AnalystsHold · 18Stronger: Buy · 15
From its 200-day averageStronger: +20.1%+6.9%

Share price over the past year

  • Givaudan+22.9%
  • Novonesis A/S+10.2%

17 Nov 202518 Nov 2026

Givaudan or Novonesis A/S: which is stronger?

  • NSIS-B.CO

    Which is more profitable?

    Novonesis A/S keeps more of each sale as profit: 15.6% against 12.9%.

  • NSIS-B.CO

    Which is growing its sales faster?

    Novonesis A/S is growing its sales faster: +7.10% over the past year, against −1.70%.

  • NSIS-B.CO

    Which has borrowed less?

    Novonesis A/S has borrowed less: its debt is 27.9% of what its shareholders own, against 110.8% for Givaudan.

  • NSIS-B.CO

    Which costs less for the profit it is expected to make?

    Novonesis A/S costs less for the profit it is expected to make: 26.0× its forward earnings, against 30.1×.

  • GIVN.SW

    Which pays more in dividends?

    Givaudan pays more back in dividends for what a share costs: 1.77% a year, against 1.46%.

  • NSIS-B.CO

    Which do analysts rate higher?

    Analysts are warmer on Novonesis A/S: Buy, against Hold for Givaudan.

  • GIVN.SW

    Which is in the stronger price trend?

    Givaudan's price is in the stronger trend: 20.1% above its 200-day average, against 6.9% above.

What each company does

GIVN.SWGivaudan

Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry.

Reports results on 27 January 2027

NSIS-B.CONovonesis A/S

Novonesis A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America.

Reports results on 24 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European basic materials comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.